Learn more about whether Corcept Therapeutics Incorporated or Haleon plc is a better investment based on AAII's A+ Investor ...
Sei Investments Co. cut its stake in shares of Haleon plc (NYSE:HLN – Free Report) by 1.6% during the 4th quarter, Holdings ...
According to Arizton’s latest research report, the US weight loss dietary supplements market is growing at a CAGR of 2.74% ...
(Sharecast News) - London stocks had extended losses by midday on Monday as Donald Trump rattled markets yet again, threatening to impose reciprocal tariffs on "all countries". The FTSE 100 was down 1 ...
The US bone and joint health supplements market is experiencing substantial growth, driven by evolving consumer preferences ...
Haleon PLC closed 6.66% short of its 52-week high of £4.18, which the company reached on March 4th.
Pfizer's $25 support holds strong, with institutional buying signals and growth potential in oncology. Click here to read an ...
The "Enterprise Tech Ecosystem Series: Haleon - 2025" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into the Haleon's tech activities, including its ...
Retail marketing campaigns that engaged consumers at the point of purchase took centre stage at the 2025 Shop! ANZ Retail ...
Haleon launched a share buyback programme of up to £330m on Friday, representing the remaining portion of the £500m allocated ...
In early corporate news, SSE names Chief Commercial Officer Martin Pibworth as its new chief executive designate, while WH Smith agrees the sale of its UK High Street business. Here is what you need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results